EIKON THERAPEUTICS
Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.
EIKON THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2019-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.eikontx.com
Total Employee:
101+
Status:
Active
Total Funding:
666 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizons Ventures
Horizons Ventures investment in Series B - Eikon Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Eikon Therapeutics
E15 VC
E15 VC investment in Series B - Eikon Therapeutics
General Catalyst
General Catalyst investment in Series B - Eikon Therapeutics
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series B - Eikon Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Eikon Therapeutics
Lux Capital
Lux Capital investment in Series B - Eikon Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Eikon Therapeutics
AME Cloud Ventures
AME Cloud Ventures investment in Series B - Eikon Therapeutics
Soros Capital Management
Soros Capital Management investment in Series B - Eikon Therapeutics
Official Site Inspections
http://www.eikontx.com Semrush global rank: 3.47 M Semrush visits lastest month: 4.35 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eikon Therapeutics"
Eikon Therapeutics Builds Leading Clinical Development …
Jun 1, 2023 HAYWARD, Calif. – Eikon Therapeutics, Inc., a clinical stage biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of …See details»
Eikon Therapeutics
Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise HAYWARD, Calif. – Eikon Therapeutics, Inc., a clinical stage biotechnology company that is …See details»
Eikon Therapeutics Builds Leading Clinical Development …
Jun 1, 2023 HAYWARD, Calif.--(BUSINESS WIRE)--Eikon Therapeutics, Inc., a clinical stage biotechnology company that is advancing breakthrough therapeutics through the purposeful …See details»
Eikon Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (341) 777-0566 Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover …See details»
Eikon Therapeutics - LinkedIn
Eikon Therapeutics | 21,629 followers on LinkedIn. Pioneering a new method of drug discovery based on tracking and measuring movement of individual proteins in live cells | Eikon Therapeutics is a ...See details»
Eikon Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Eikon Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
This Startup Raised Over $500 Million To Find Better …
Jan 6, 2022 Roger Perlmutter, CEO of Eikon. Eikon Therapeutics. In 2014, the Nobel Prize in Chemistry was awarded to three men whose work helped change the way microscopes work.For centuries, in order to ...See details»
Eikon Therapeutics Announces Business Update …
Sep 11, 2023 “The continued progress of our clinical-stage programs is a testament to our emerging clinical development organization which includes experienced industry professionals who collectively have contributed to more …See details»
Eikon Therapeutics Management to Present at the Morgan Stanley …
Aug 26, 2024 Eikon operates from its facilities in California, New Jersey, and New York and can be found online at www.EikonTx.com or LinkedIn. Colin Sanford [email protected].See details»
Eikon Therapeutics - VentureRadar
"Eikon is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells. The invention of fluorescence microscopy made …See details»
Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets
Jun 1, 2023 New assets establish foundation for Eikon’s expanding pipeline of in-house and acquired drug candidates with applications in oncology and other therapeutic areasSee details»
Eikon Therapeutics to Provide Corporate Updates at the 42nd …
HAYWARD, Calif., January 08, 2024--Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, …See details»
Perlmutter named CEO of Eikon, a biotech with $148M to apply …
May 5, 2021 Roger Perlmutter, M.D., Ph.D., has taken up the CEO post at Eikon Therapeutics. The startup disclosed the hiring of the former president of Merck Research Laboratories …See details»
Eikon Therapeutics Announces Business Update, Highlighting …
Sep 11, 2023 “The continued progress of our clinical-stage programs is a testament to our emerging clinical development organization which includes experienced industry professionals …See details»
Eikon Therapeutics Announces Appointment of Michael Klobuchar …
Nov 20, 2024 Prior to this role, Mr. Klobuchar was Senior Vice President, CFO, and Head of Portfolio and Alliance Management for MRL and led the Global Portfolio and Alliance …See details»
Super-resolution microscopy startup Eikon raises $518M for 'drug ...
Jan 6, 2022 — Eikon Therapeutics (@EikonTX) January 6, 2022. Live-cell imaging platform Eikon’s CEO Roger Perlmutter, who was hired when the company raised its series A tranche …See details»
Eikon Therapeutics - Overview, News & Similar companies
View Eikon Therapeutics (www.eikontx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Eikon Therapeutics Announces Multiple Abstracts to be Presented …
May 28, 2024 Eikon operates from its facilities in California, New Jersey, and New York and can be found online at www.EikonTx.com or LinkedIn. Media Contact: Colin Sanford. …See details»
Eikon Therapeutics to Provide Corporate Updates
Jan 8, 2024 Phase 2 study initiated investigating the company’s Toll-Like Receptor 7 and 8 co-agonist, EIK1001; Enrolling patients in Phase 1 trial of highly selective PARP1 inhibitor, EIK1003See details»